Kawamura Ai, Miyagawa Shigeru, Fukushima Satsuki, Kawamura Takuji, Kashiyama Noriyuki, Ito Emiko, Watabe Tadashi, Masuda Shigeo, Toda Koichi, Hatazawa Jun, Morii Eiichi, Sawa Yoshiki
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Sci Rep. 2016 Jan 14;6:19464. doi: 10.1038/srep19464.
Transplantation of induced pluripotent stem cell-derived cardiac tissue constructs is a promising regenerative treatment for cardiac failure: however, its tumourigenic potential is concerning. We hypothesised that the tumourigenic potential may be eliminated by the host immune response after allogeneic cell transplantation. Scaffold-free iPSC-derived cardaic tissue sheets of C57BL/6 mouse origin were transplanted into the cardiac surface of syngeneic C57BL/6 mice and allogeneic BALB/c mice with or without tacrolimus injection. Syngeneic mice and tacrolimus-injected immunosuppressed allogeneic mice formed teratocarcinomas with identical phenotypes, characteristic, and time courses, as assessed by imaging tools including (18)F-fluorodeoxyglucose-positron emission tomography. In contrast, temporarily immunosuppressed allogeneic mice, following cessation of tacrolimus injection displayed diminished progression of the teratocarcinoma, accompanied by an accumulation of CD4/CD8-positive T cells, and finally achieved complete elimination of the teratocarcinoma. Our results indicated that malignant teratocarcinomas arising from induced pluripotent stem cell-derived cardiac tissue constructs provoked T cell-related host immune rejection to arrest tumour growth in murine allogeneic transplantation models.
诱导多能干细胞衍生的心脏组织构建体移植是一种有前景的心力衰竭再生治疗方法;然而,其致瘤潜力令人担忧。我们假设,同种异体细胞移植后,宿主免疫反应可能会消除致瘤潜力。将无支架的源自C57BL/6小鼠的诱导多能干细胞衍生的心脏组织片移植到同基因C57BL/6小鼠和异基因BALB/c小鼠的心脏表面,其中部分小鼠注射或未注射他克莫司。通过包括(18)F-氟脱氧葡萄糖-正电子发射断层扫描在内的成像工具评估,同基因小鼠和注射他克莫司的免疫抑制异基因小鼠形成了具有相同表型、特征和时间进程的畸胎癌。相比之下,在停止注射他克莫司后,暂时免疫抑制的异基因小鼠畸胎癌进展减缓,伴有CD4/CD8阳性T细胞的积累,最终畸胎癌完全消除。我们的结果表明,在小鼠同种异体移植模型中,诱导多能干细胞衍生的心脏组织构建体产生的恶性畸胎癌引发了T细胞相关的宿主免疫排斥反应,从而阻止了肿瘤生长。